Androgen regulation of beta-amyloid protein and the risk of Alzheimer's disease.
Advancing age is the most significant risk factor for the development of Alzheimer's disease (AD), however the age-related changes that underlie this effect remain unclear. In men, one normal consequence of aging is a robust decline in circulating and brain levels of the sex steroid hormone testosterone. Testosterone depletion leads to functional impairments and increased risk of disease in androgen-responsive tissues throughout the body, including brain. In this review we discuss the relationship between age-related testosterone depletion and the development of AD. Specifically, we focus on androgen regulation of beta-amyloid protein (Abeta), the accumulation of which is a key initiating factor in AD pathogenesis. Emerging data suggest that the regulatory actions of androgens on both Abeta and the development of AD support consideration of androgen therapy for the prevention and treatment of AD.
Davis School of Gerontology, University of Southern California, 3715 McClintock Avenue, Los Angeles, CA 90089-0191, USA.
Emily R
ER
Rosario
Christian J
CJ
Pike
D000544:Alzheimer Disease / Q000378:metabolism* / Q000473:pathology; D016229:Amyloid beta-Peptides / Q000378:metabolism*; D000728:Androgens / Q000378:metabolism*; D000818:Animals; D001921:Brain / Q000473:pathology / Q000502:physiology*; D006801:Humans; D008297:Male; D012307:Risk Factors; D013739:Testosterone / Q000378:metabolism*
D016229:Amyloid beta-Peptides; D000728:Androgens; D013739:Testosterone